Proteon Pharmaceuticals S.A.

Tweet this page
<
2022
2023
2024
>
Registration as it was on 26 Mar 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

None declared

None declared

Lobbyists (Full time equivalent)

0.2 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Proteon Pharmaceuticals S.A.

    EU Transparency Register

    471491246404-54 First registered on 05 May 2022

    Goals / Remit

    Proteon Pharmaceuticals is an innovative European biotechnology company. We have built and are scaling a technological platform to deliver a novel class of natural antibacterial using the microbiome. Our mission is to modulate the microbiome, improving animal and human health. Our products will help remove unnecessary antibiotic use from the food chain, increase environmental sustainability, improve economic efficiency, improve human health, and enhance animal welfare.

    Main EU files targeted

    Revision of Regulation (EC) No 1831/2003 on additives for the use in animal nutrition
    Farm to Fork agenda
    EU Green Deal

    Address

    Head Office
    Ul. Tylna 3a
    Łódź 90-364
    POLAND
    EU Office
    Ul. Tylna 3a
    Łódź 90-364
    POLAND

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    10%2

    Lobbyists (Full time equivalent)

    0.2

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 30 Apr 2024

    Name Start date End Date
    Mr Jaroslaw DASTYCH 22 Jun 2022 22 Jun 2023
    Mr Benjamin HALL 02 Jun 2022 02 Jun 2023

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Fefana: https://fefana.org/our-association/fefana-members/?tag=p

    Member organisations

    None

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    None declared

    Lobbying costs for closed financial year

    None declared

    Major contributions in closed year

    None declared

    Major contributions in current year

    TypeNameAmount
    Grant EU 378,000€

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    Name
    eppa

    Closed year Costs

    None declared

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Consultation with MEPs and their advisors who are supportive of phage use in the EU and beyond. For example, discussion with MEP Adam Jarubas, discussion with Tara Hadviger (Policy Advisor to MEP Tiemo Wolken).

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 07 Dec 2022 Location Brussels
      Subject Presenting the company, its technology and a pathway to unlocking the full potential of bacteriophages in Europe
      DG Agriculture and Rural Development
      Attending
      • Wolfgang Burtscher (Director-General)
Download this datacard